What the Latest Long COVID Biomarker Study Actually Shows

The study identifies a consistent immune signature across a modest cohort. That is genuinely useful. What it does **not** do is establish a diagnostic test. The sample is small, the controls are imperfect, and replication is pending. I'd rather be cautiously encouraged than loudly certain.